Cargando…

Immune and hemorheological changes in Chronic Fatigue Syndrome

BACKGROUND: Chronic Fatigue Syndrome (CFS) is a multifactorial disorder that affects various physiological systems including immune and neurological systems. The immune system has been substantially examined in CFS with equivocal results, however, little is known about the role of neutrophils and na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brenu, Ekua W, Staines, Donald R, Baskurt, Oguz K, Ashton, Kevin J, Ramos, Sandra B, Christy, Rhys M, Marshall-Gradisnik, Sonya M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829521/ https://www.ncbi.nlm.nih.gov/pubmed/20064266 http://dx.doi.org/10.1186/1479-5876-8-1

Ejemplares similares

High-Throughput Sequencing of Plasma MicroRNA in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W., et al.
Publicado: (2014)

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
por: Johnston, Samantha, et al.
Publicado: (2013)

Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Postulated vasoactive neuropeptide immunopathology affecting the blood–brain/blood–spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
por: Staines, Donald R, et al.
Publicado: (2009)

A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis
por: Brenu, Ekua W., et al.
Publicado: (2016)

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W, et al.
Publicado: (2011)

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
por: Staines, Donald R, et al.
Publicado: (2009)

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis
por: Brenu, Ekua W, et al.
Publicado: (2012)

A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis
por: Johnston, Samantha C, et al.
Publicado: (2014)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Peterson, D., et al.
Publicado: (2015)

Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2021)

Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients
por: Johnston, Samantha C, et al.
Publicado: (2016)

Natural killer cells in patients with severe chronic fatigue syndrome
por: Brenu, E. W., et al.
Publicado: (2013)

Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Huth, T. K., et al.
Publicado: (2016)

Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Balinas, Cassandra, et al.
Publicado: (2019)

Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans
por: Thapaliya, Kiran, et al.
Publicado: (2020)

Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review
por: Du Preez, Stanley, et al.
Publicado: (2021)

Intra brainstem connectivity is impaired in chronic fatigue syndrome
por: Barnden, Leighton R, et al.
Publicado: (2019)

Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Chacko, Anu, et al.
Publicado: (2016)

A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Johnston, Samantha, et al.
Publicado: (2016)

Impact of Life Stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms: An Australian Longitudinal Study
por: Balinas, Cassandra, et al.
Publicado: (2021)

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Cabanas, Helene, et al.
Publicado: (2019)

Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID)
por: Huth, Teilah Kathryn, et al.
Publicado: (2020)

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56(dim)CD16(+) and CD56(bright)CD16(dim/−) natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Huth, Teilah Kathryn, et al.
Publicado: (2016)

A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)
por: Corbitt, Matthew, et al.
Publicado: (2019)

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome
por: Eaton-Fitch, Natalie, et al.
Publicado: (2019)

Brain function characteristics of chronic fatigue syndrome: A task fMRI study
por: Shan, Zack Y., et al.
Publicado: (2018)

Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study
por: Shan, Zack Y., et al.
Publicado: (2016)

The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort
por: Close, Shara, et al.
Publicado: (2020)

Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Marshall-Gradisnik, Sonya, et al.
Publicado: (2016)

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
por: Eaton, Natalie, et al.
Publicado: (2018)

Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome
por: Barnden, Leighton R., et al.
Publicado: (2018)

A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease
por: Holden, Sean, et al.
Publicado: (2020)

Network Analysis of Symptoms Co-Occurrence in Chronic Fatigue Syndrome
por: Kujawski, Sławomir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vv0uo5d7bboh8emh6rq8m1tfer